Moreover, it has been shown by other authors that prostate tumors could interact with the surrounding benign prostate epithelium, by downregulating some biomarkers (i.e., microseminoprotein-beta, MSMB), and that this response could be associated with tumor aggressiveness [33]. Here, MSMB is linked to prostate neoplasm.